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Background: Hypertensive disorders of pregnancy are the most common causes of adverse maternal & perinatal
outcomes. Such investigations in resource limited settings would help to have great design strategies in preventing
maternal and perinatal morbidity and mortality.
Aim: To determine management outcome and factor associated with pregnancy related hypertensive disorder in
Mettu Karl Referral Hospital, Mettu, Ethiopia.
Method: A retrospective study deign was conducted at Mettu Karl Referral Hospital from 1st January 2010 to
December 1st 2013 by reviewing medical records and logbooks. Descriptive, binary and multiple logistic regression
analysis were used. A 95% CI and P- value of < 0.05 were considered statistically significant.
Result: The magnitude of pregnancy related hypertensive disorder was 2.4%. Majority 82.6% of the mothers were
in the age range between 18 to 34 year with a mean age and standard deviation (SD) of 24.4 (SD ± 5.12). Sever
preeclampsia was the most prevalent diagnosis made to 35.5% of the mother, followed by 19% cases of eclampsia
and 12.4% of HELLP. Fetal management outcomes indicates 120.37 perinatal mortality per 1000 deliveries and a
stillbirth rate of 10.2%, low birth weight of 30.5%, and low APGAR score of 18.5%, abortion 10.7% and preterm
delivery 31.4%.
Conclusion: In this study severe preeclampsia is the most common of all pregnancy related hypertension disorders
followed by Eclampsia. Fetal complications like low Apgar score and preterm deliveries were statistically significant
and associated with fetal management outcomes.
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Preeclampsia is a hypertensive disorder of pregnancy,
which usually manifests after 20 weeks of gestation with
hypertension and proteinuria,while hypertension being
defined with blood pressure at least 140 mm Hg for sys-
tolic and/or 90 mm Hg for diastolic on at least two oc-
casions and at least 4—6 hrs apart in women known to
be normotensive beforehand [1-3]. Severe hypertension
is considered if sustained rises in blood pressure to the
level of > = 160 mm Hg for systolic), and/or 110 mm Hg
for diastolic, [1,3,4]. When convulsions occur in addition* Correspondence: mtesfaye1@gmail.com
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unless otherwise stated.to these signs, of preeclampsia the condition is referred
to as eclampsia [5].
Preeclampsia is primarily a disorder of nulliparous, but
multiparous pregnant women with a new partner have an
elevated risk of preeclampsia similar to that of nulliparous
women [6]. Delivery of placenta is the only treatment yet
known, indicating placenta is the primary sponsor to the
pathogenesis of preeclampsia [7].
Following the drama of hypertensive disorders during
pregnancy, 12–22% of all pregnancies, have a tragic story
[8,9]. Increased mortality and morbidity as a result of
Preeclampsia during pregnancy is not only a terror to the
mother but also to the fetus [10]. Preeclampsia has hang
around till this century and continues being public health
concern in both developed and developing countries [11].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Perinatal outcome of mothers with hypertensive disorder of pregnancy
Perinatal outcome Type of hypertension (Hypertensive disorder of pregnancy)
Mild preeclampsia Sever preeclampsia HELLP Eclampsia Gestational Chronic
No (%) No (%) No (%) No (%) No (%) No (%)
Fetal weight (grams)
Wt.≥ 2500 13 (72.2) 26 (60.5) 3 (20.0) 15 (65.2) 14 (87.5) 4 (66.7)
Wt. = 1000-2499 5 (27.8) 12 (27.9) 9 (60.0) 6 (26.1) 1 (6.2) 0 (0.0)
Fetal outcome
Stil birth 2 (11.1) 6 (14.0) 3 (20.0) 0 (0.0) 0 (0.0) 0 (0.0)
Low APGAR/<7/ 2 (11.1) 7 (16.7) 4 (26.7) 3 (13.0) 3 (18.8) 1 (16.7)
Abortion 0 (0.0) 5 (11.6) 3 (20.0) 2 (8.7) 1 (6.2) 2 (33.3)
Neonatal outcome
Early neonatal
Death 0 (0.0) 1 (2.3) 0 (0.0) 0 (0.0) 1 (6.2) 0 (0.0)
HELLP-Hemolytic Elevated Liver enzyme and low platelet.
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antenatal care, illiteracy, lack of awareness and poverty in
developing countries continues to favor these nightmares
of pregnant mothers [8]. Thus, the aim of this study is to
highlight the management outcome and factor associ-
ated with pregnancy related hypertensive disorder in an
Ethiopian hospital.
Materials and methods
Study setting and period
This study was conducted from 1st January 2010 to
December 1st 2013 in Mettu karl hospital. The hospital
has 138 health professionals in different disciplines. The
number of pregnant mother in the catchment per year is
55,860. There are a total of 160 beds in all wards of
which 47 beds (38 gynacology and 9 in obstetrics) and
three delivery coaches.
Study design and participants
A three years hospital based retrospective study design
was implemented to determine management outcome and
factor associated with pregnancy related hypertensive dis-
orders. All pregnant mothers who gave birth at Metu karl
hospital over the study period (three years) were included
for the review.Figure 1 Percentage of mothers with unfovorable outcome (n = 121).Instruments and data collection methods
The data for this study was obtained from admission
registration logbooks, delivery registration books and
patient charts. The data was collected using a pre-tested
check list questioner which was a socio-demographic
variables, obstetrics history, sign and symptoms at pres-
entation, laboratory result, maternal and fetal outcomes.
The data collectors were given two days training on
how to review and abstract the required and pertinent
information from the main document. Data collection
tools (the checklists) to collect the data from the
registration books and client cards was prepared and
pretested with similar group as the target group and
excluded from the sample. To assure the quality of the
data, data collectors was supervised by principal investi-
gator every day.Ethical statement
Ethical approval is obtained from Ethical review board
of Jimma University, College of Public Health & Medical
Science. Metu karl Hospital gives permission to conduct
the study. Then, study participants had also gave in-
formed written consent. The privacy of mothers was
kept confidential.
Figure 2 Percentage of unfavorable fetal outcome (n = 108). ENND-Early Neonatal Death.
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The collected data were manually checked for complete-
ness and for any inconsistency then coded and entered
into SPSS version 16.0 for data processing and analysis.
Descriptive, binary and multiple logistic regression ana-
lysis were used. On binary logistic regression analysis, a
p-value ≤ 0.25 was used as a candidate for multiple logis-
tic regression analysis. A 95% CI and P- value of <0.05
was considered statistically significant and crude/ad-
justed odds ratio calculated.
Result
Socio demographic characteristics
A total of 5415 pregnant mothers admitted to Mettu
karl obstetrics ward for delivery from January 1st 2010-
December 30/2013 and their record was reviewed of
which 130 mothers were found to have the diagnosis of
pregnancy related hypertensive disorder. Among these
121 (93%) mothers who have a record of HDP were re-
trieved for further analysis. The minimum and max-
imum age of the mother were 15 and 39 respectively
with a mean and standard deviation of 24.4 (SD ± 5.12).
The majority 100 (82.6%) of the mothers were in the age
range between 18 to 34 years. As to their residence and
background information, 84 (69.8%) were from outsideTable 2 Onset of labor and intervension of mothers with hyp





Elective Cesarean 2 (66.7)
Mode of delivery
Vaginal 56 (62.9)






Antihypertensive + anticonvulsant 59 (72.8)of Mettu town, 62 (51.2%) un-booked for antenatal care
follow up, and 63 (52.1%) were primiparous.
Majority 58 (47.9%) of the mother presented to the
Hospital with a chief complain of headache. Nearly 87
(71.9%) of the mother had maximum blood pressure
record of BP ≥ 16o/110. Sever preeclampsia is the most
common hypertensive disorder of pregnancy accounting
35.5%, followed by eclampsia which contributed 19%,
mild preeclampsia 14.9%, HELLP syndrome 12.4%, ges-
tational HTN 13.2%, and chronic HTN 4.1% and two pa-
tients were superimposed preeclampsia Table 1.
There were eight mothers with HDP complicated with
renal failure (6.6%), nine (7.4%) with postpartum hemorrhage
and two with abruptio placenta and there was no maternal
death during the study period (Figure 1).
In this study of all 108 mothers with unfavorable fetal
outcomes, the perinatal mortality rate was 120.37 per
thousand deliveries and 11 still births yielding the still
birthrate of 10.185%. The rate of low and very low birth
weight were 24.8% and 3.3% respectively and there were
20 (18.5%) low APGAR score and preterm delivery 34
(28.1%) among 108 deliveries .there were 2 early neonatal
death and 13 (10.7%) abortion (Figure 2).
As to the management of mothers, 2 (1.7%) of them were
managed conservatively, 38 (31.4%) with anti-hypertensive,ertensive disorder of pregnancy
ertensive disorder of pregnancy)
Eclampsia Gestational Chronic
15 (25) 10 (16.7) 2 (3.3)
8 (13.8) 5 (8.6) 4 (6.9)
0 (0) 1 (33.3) 0. (0)
19 (21.3) 9 (10.1) 5 (5.6)
2 (9.5%) 7 (33.3) 1 (4.8)
2 (22.2) 0 (0) 0 (0)
0 (0) 0 (0) 0 (0)
0 (0) 2 (100) 0 (0)
2 (5.3) 14 (36.8) 5 (13.2)
21 (25.9) 0 (0) 1 (1.2)
Table 3 Binary logistic regression on factors associated with material management outcomes
Variables Management outcomes COR (95% CI)
Address Favorable Un-favorable
Metu 12 25 1
Out metu 14 70 2.40 (.98-5.88)
Parity
Multipara 12 46 1
Nullipara 142 46 0.91 (0.38-2.18)
Antenatal care
Yes 13 45 0.68 (0.28-1.64)
No 13 50 1
Gestational age
Term 20 55 1
Preterm 5 29 2.11 (0.72-6.20)
Abortion 1 11 4.00 (0.49-33.00)
Maximum BP
140/90-159/109 mm Hg 18 16 1
>160/110 mm Hg 8 79 11.11 (4.12-29.93)*
Urine albumin
Negative 14 7 1
Positive 46 54 10.88 (3.78-31.27)*
Length of hospital stay
<7 7 8 1
>or = 7 13 52 2.03 (.75-5.54)
*Significant at p-value ≤ 0.001 is reference logical reference.
-BP: blood presusure.
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convulsant medications. On the other hand, onset of labor
was spontaneous for 60 (49.6%) of the mother, and induction
was made to 58 (47.9%) while elective cesarean delivery
was made to 3 (2.5%) of the mother. Majority of the mothers
delivered with spontaneous vaginal delivery 89 (73.6%),
cesarean delivery 21 (17.4%), forceps/vacuum 9 (7.4%) and
two destructive delivery (Table 2).
Predictors of maternal management outcomes of HDP
Five of the variables were found to be candidates in the
binary logistic analysis for the final model. Therefore, a
multivariate approach was applied to determine which
factors best explained and predict maternal management
outcome.
The outcome of the final multiple logistic regression
models indicated that address, gestational age and length of
hospital stay dropped from the final model. In this analysis
maximum blood pressure record has significant statistical
association with maternal management outcome of HDP
(AOR= 26, 95% CI: 5.11-132.35, p-value = 0.001). The pres-
ence of albumin in the urine has statistical association with
maternal management outcomes of HDP (AOR= 37.15,
95% CI: 6.58-209.85, p-value = 0.001. Mothers who hadProteinuria were more likely to develop unfavorable out-
come as compared with mothers with negative Proteinuria
(Table 3).Predictors of fetal management outcomes of HDP
Seven of the variables were found to be significantly asso-
ciated in the binary logistic analysis. Therefore, a multi-
variate approach was applied to determine which factors
best explained and predict maternal management out-
come. The outcome of the final stepwise multiple logistic
regression models indicated that address, antenatal care,
maximum blood pressure record, urine albumin, and
length of hospital stay dropped from the final model.
In this analysis gestational age has significant statistical
association with fetal management outcome of HDP
(AOR= 80.4, 95% CI: 12.68-509.67, p-value <0.001). Pre-
term newborns are more likely to develop unfavorable
fetal outcome as compared with term. APGAR score has
significant statistical association with fetal management
outcome of HDP (AOR= 22.96, 95% CI: 3.08-171.21,
p-value = 0.002). Newborns with low APGAR score are
more likely to develop unfavorable fetal outcome as com-
pared with newborns with good APGAR score (Table 4)
Table 4 Bivariate on factors associated with fetal management outcomes
Variables Management outcomes COR (95% CI)
Favorable Un-Favorable
Address
Metu 22 15 1
Out metu 38 46 1.81 (0.82-3.98)
Parity
Multipara 29 29 1
Nullipara 31 32 0.97 (0.48-1.99)
Gestational age
Term 60 15 1
Preterm 3 31 41.33 (11.12-153.68)*
Antenatal care
Yes 32 26 0.34 (0.16-0.73)
No 28 35 1
Maximum BP
140/90-159/109 mm Hg 22 12 1
>160/110 mm Hg 38 49 2.06 (0.91-4.67)
Albimin
Negative 14 7 1
Positive 46 54 2.08(0.78-5.59)
APGAR
>or = 7 60 29 1
<7 3 17 11.72 (3.18-43.23)*
Length of hospital stay
<7 days 47 32 1
>7 days 16 26 2.39 (1.11-5.14)
*Significant at p-value ≤ 0.05 1 is reference logical reference.
-BP: blood pressure.
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Geographic regions of the world reflect various prevalence
of hypertensive disorder of pregnancy, from the lowest
1.5% in Sweden to 7.5% in Brazil [12,13]. In developing
countries the pooled incidence of preeclampsia is 3.4%
[14]. However recent analysis of large database from 29
countries, estimates the global distribution of the inci-
dence of all deliveries to be 0.29%, 2.16% and 0.28%
for chronic hypertension, pre-eclampsia and eclampsia
respectively [15].
The magnitude of pregnancy related hypertensive dis-
order in our study was 2.4%. Severe preeclampsia was
common in 35.5% of pregnant mothers and followed by
eclampsia. This is not surprising giving the fact that
most of the mothers were young ages and with low so-
cioeconomic status. This has been widely investigated
in the past decade and now a days being primigravida,
living in low socio economic status and young ages are
the characteristics of hypertensive disorder of pregnancy
[12,16-18]. Placental abruption was as low as 2% in ourcase compared to some studies who reported as high as
20% [19], this might be explained to adequate blood
pressure monitoring as no maternal death or intracranial
hemorrhage is recorded. In line with many other studies
[20], 71.9% of our mothers had maximum blood pressure
record which read ≥16o/110 and HELLP syndrome in
12.4% of the cases.
A multivariate approach was applied to determine
which factors best explained and predict maternal man-
agement outcome. The outcome of the final stepwise
multiple logistic regression models indicated that ad-
dress, antenatal care, maximum blood pressure record,
urine albumin, and length of hospital stay dropped
from the final model. Other studies also reflected socio-
economic status and antenatal care provision plays the
same role as biochemical markers of preeclampsia like
urine albumin [19,21,22].
Concerning with the management of our patients the
hospital being well equipped and well- staffed and giving
service for 24 hours, early presentation of the mothers
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to no maternal death. In developed countries pregnancy
related acute renal failure has decreased, current estimates
are around 1–2.8% [23], where as in developing countries
it is higher and responsible for both maternal and fetal
morbidity and mortality [20]. Some setups showed an
alarmingly high values to a 36% [24]. Our investigation in-
dicated the incidence to be 6.6%, which is relatively
low this might be due to liberalization with abortion laws,
improved health care facilities and more effective measures
of care full prevention. On top of this Mettu Karl hospital
is well staffed and well equipped hospital compared to
other national hospitals in the country.
In our analysis maximum blood pressure record has
significant statistical association with maternal manage-
ment outcome of HDP (AOR = 26, 95% CI: 5.11-132.35,
p-value <0.001). The presence of albumin in the urine
has statistical association with maternal management
outcomes of HDP (AOR = 37.15, 95% CI: 6.58-209.85,
p-value <0.001. Mothers who had Proteinuria were more
likely to develop unfavorable outcome as compared with
mothers with negative Proteinuria.
Additionally fetal outcome was affected by gestational
age with significant statistical association (AOR = 80.4, 95%
CI: 12.68-509.67, p-value <0.001) as well with the Apgar
score (AOR = 22.96, 95% CI: 3.08-171.21, p-value = 0.002).
Preterm newborns are more likely to develop unfavorable
fetal outcome as compared with term ones. APGAR score
has significant statistical association with fetal management
outcome of HDP. Newborns with low Apgar score are
more likely to develop unfavorable fetal outcome as com-
pared with newborns with good Apgar score.
In conclusion we say both maternal and fetal outcome
is highly dependent on socio-economic status, gesta-
tional age and maximum blood pressure of the mother.
We recommend effective and competent health service
provision through antenatal care and close follow up
and management with available resources could improve
mortality and morbidity as shown here with low frequencies
of complications like renal failure, HELLP syndrome, placental
abruption and no maternal death in this referral hospital
with a huge catchment area.
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